Bladder cancer is where a growth of abnormal tissue, known as a tumour, develops in the bladder lining. In some cases, the tumour spreads into the bladder muscle. The most common symptom of bladder cancer is blood in urine, which is usually painless. If you notice blood in your urine, even if it comes and
goes, you should visit your GP, so the cause can be investigated. Read about the symptoms of bladder cancer. Once diagnosed, bladder cancer can be classified by how far it has spread. If the cancerous cells are contained inside the lining of the bladder, doctors
describe it as non-muscle-invasive bladder cancer (early bladder cancer). This is the most common type of bladder cancer. When the cancerous cells spread beyond the lining, into the surrounding bladder muscle, it's referred to as muscle-invasive bladder cancer (or invasive bladder cancer). This is less common, but has a higher chance of spreading to other parts of the body. If bladder cancer has spread to other parts
of the body, it's known as advanced or metastatic bladder cancer. Read more about diagnosing bladder cancer. Most cases of bladder cancer appear to be caused by exposure to harmful substances, which lead to abnormal changes in the bladder's cells over many years. Tobacco
smoke is a common cause and it's estimated that more than 1 in 3 cases of bladder cancer are caused by smoking. Contact with certain chemicals previously used in manufacturing is also known to cause bladder cancer. However, these substances have since been banned. Read more about the causes of bladder cancer. In cases of non-muscle-invasive bladder cancer, it's usually possible to remove the cancerous cells while leaving the rest of the bladder intact. This is done using a surgical technique called transurethral resection of a bladder tumour (TURBT). This is followed by a dose of chemotherapy medicines directly into the bladder, to reduce the risk of the cancer returning. In cases with a
higher risk of recurrence, medicine known as Bacillus Calmette-Guérin (BCG) may be injected into the bladder to reduce the risk of the cancer returning. Treatment for high-risk non-muscle-invasive bladder cancer, or muscle-invasive bladder cancer may involve surgically removing the bladder in an operation known as a cystectomy.Types of bladder cancer
Causes of bladder cancer
Treating
bladder cancer
Most patients will have a choice of either surgery or a course of radiotherapy.
When the bladder is removed, you'll need another way of collecting your urine. Possible options include making an opening in the abdomen so urine can be passed into an external bag, or constructing a new bladder out of a section of bowel. This will be done at the same time as a cystectomy.
After treatment for all types of bladder cancer, you'll have regular follow-up tests to check for signs of recurrence.
Read more about treating bladder cancer.
Who is affected?
About 10,000 people are diagnosed with bladder cancer every year and it's the 11th most common cancer in the UK.
The condition is more common in older adults, with most new cases diagnosed in people aged 60 and above.
Bladder cancer is also more common in men than in women, possibly because in the past, men were more likely to smoke and work in the manufacturing industry.
Page last reviewed: 01 July 2021
Next review due: 01 July 2024
- ICD-10-CM Codes ›
- C00-D49 Neoplasms ›
- C64-C68 Malignant neoplasms of urinary tract ›
- C67- Malignant neoplasm of bladder ›
- 2023 ICD-10-CM Diagnosis Code C67.4
2023 ICD-10-CM Diagnosis Code C67.4
- 2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- C67.4 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2023 edition of ICD-10-CM C67.4 became effective on October 1, 2022.
- This is the American ICD-10-CM version of C67.4 - other international versions of ICD-10 C67.4 may differ.
The following code(s) above C67.4 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to C67.4:
- C00-D49
2023 ICD-10-CM Range C00-D49
Neoplasms
Note
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
Approximate Synonyms
- Adenocarcinoma, posterior wall of bladder
- Cancer of the urinary bladder, posterior wall
- Primary adenocarcinoma of posterior wall of urinary bladder
- Primary malignant neoplasm of posterior wall of urinary bladder
- Primary squamous cell carcinoma of posterior wall of urinary bladder
- Primary transitional cell carcinoma of posterior wall of urinary bladder
- Squamous cell carcinoma, posterior wall of bladder
- Transitional cell carcinoma, posterior wall of bladder
ICD-10-CM C67.4 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
- 656 Kidney and ureter procedures for neoplasm with mcc
- 657 Kidney and ureter procedures for neoplasm with cc
- 658 Kidney and ureter procedures for neoplasm without cc/mcc
- 686 Kidney and urinary tract neoplasms with mcc
- 687 Kidney and urinary tract neoplasms with cc
- 688 Kidney and urinary tract neoplasms without cc/mcc
Convert C67.4 to ICD-9-CM
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
ICD-10-CM Codes Adjacent To C67.4
C65.9 Malignant neoplasm of unspecified renal pelvis
C66 Malignant neoplasm of ureter
C66.1 Malignant neoplasm of right ureter
C66.2 Malignant neoplasm of left ureter
C66.9 Malignant neoplasm of unspecified ureter
C67 Malignant neoplasm of bladder
C67.0 Malignant neoplasm of trigone of bladder
C67.1 Malignant neoplasm of dome of bladder
C67.2 Malignant neoplasm of lateral wall of bladder
C67.3 Malignant neoplasm of anterior wall of bladder
C67.4 Malignant neoplasm of posterior wall of bladder
C67.5 Malignant neoplasm of bladder neck
C67.6 Malignant neoplasm of ureteric orifice
C67.7 Malignant neoplasm of urachus
C67.8 Malignant neoplasm of overlapping sites of bladder
C67.9 Malignant neoplasm of bladder, unspecified
C68 Malignant neoplasm of other and unspecified urinary organs
C68.0 Malignant neoplasm of urethra
C68.1 Malignant neoplasm of paraurethral glands
C68.8 Malignant neoplasm of overlapping sites of urinary organs
C68.9 Malignant neoplasm of urinary organ, unspecified
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.